Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis.
Croner RS, Sevim M, Metodiev MV, Jo P, Ghadimi M, Schellerer V, Brunner M, Geppert C, Rau T, Stürzl M, Naschberger E, Matzel KE, Hohenberger W, Lottspeich F, Kellermann J. Croner RS, et al. Among authors: jo p. Int J Mol Sci. 2016 Feb 4;17(2):209. doi: 10.3390/ijms17020209. Int J Mol Sci. 2016. PMID: 26861291 Free PMC article.
Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant.
Schirmer MA, Mergler CP, Rave-Fränk M, Herrmann MK, Hennies S, Gaedcke J, Conradi LC, Jo P, Beissbarth T, Hess CF, Becker H, Ghadimi M, Brockmöller J, Christiansen H, Wolff HA. Schirmer MA, et al. Among authors: jo p. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):149-57. doi: 10.1016/j.ijrobp.2011.05.063. Epub 2011 Oct 12. Int J Radiat Oncol Biol Phys. 2012. PMID: 22000747 Clinical Trial.
Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies.
Jo P, Nietert M, Gusky L, Kitz J, Conradi LC, Müller-Dornieden A, Schüler P, Wolff HA, Rüschoff J, Ströbel P, Grade M, Liersch T, Beißbarth T, Ghadimi MB, Sax U, Gaedcke J. Jo P, et al. Sci Rep. 2016 Oct 18;6:35589. doi: 10.1038/srep35589. Sci Rep. 2016. PMID: 27752113 Free PMC article.
Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy.
Emons G, Auslander N, Jo P, Kitz J, Azizian A, Hu Y, Hess CF, Roedel C, Sax U, Salinas G, Stroebel P, Kramer F, Beissbarth T, Grade M, Ghadimi M, Ruppin E, Ried T, Gaedcke J. Emons G, et al. Among authors: jo p. Br J Cancer. 2022 Sep;127(4):766-775. doi: 10.1038/s41416-022-01842-2. Epub 2022 May 21. Br J Cancer. 2022. PMID: 35597871 Free PMC article.
Heterogeneity of KRAS Mutation Status in Rectal Cancer.
Jo P, König A, Schirmer M, Kitz J, Conradi LC, Azizian A, Bernhardt M, Wolff HA, Grade M, Ghadimi M, Ströbel P, Schildhaus HU, Gaedcke J. Jo P, et al. PLoS One. 2016 Apr 11;11(4):e0153278. doi: 10.1371/journal.pone.0153278. eCollection 2016. PLoS One. 2016. PMID: 27064574 Free PMC article.
Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.
Azizian A, Epping I, Kramer F, Jo P, Bernhardt M, Kitz J, Salinas G, Wolff HA, Grade M, Beißbarth T, Ghadimi BM, Gaedcke J. Azizian A, et al. Among authors: jo p. Int J Mol Sci. 2016 Apr 15;17(4):568. doi: 10.3390/ijms17040568. Int J Mol Sci. 2016. PMID: 27092493 Free PMC article.
47 results